4
Changes in Ownership
VirnetX Holding Corp Filed Acc 0001209191-19-004256
CTO and Chief Scientist sold 35,000 shares at an average $5.41 ($189,276)
- CTO and Chief Scientist acquired 35,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Short Robert D III CTO and Chief Scientist | 2019-01-15 | Option exercise | +35,000 | $1.15 | $40,250 | 115,866 | D |
| Short Robert D III CTO and Chief Scientist | 2019-01-15 | Sale | −10,428 | $4.71 | $49,164 | 105,438 | D |
| Short Robert D III CTO and Chief Scientist | 2019-01-15 | Sale | −21,474 | $5.61 | $120,450 | 83,964 | D |
| Short Robert D III CTO and Chief Scientist | 2019-01-15 | Sale | −3,098 | $6.35 | $19,662 | 80,866 | D |
| Derivatives | |||||||
| Short Robert D III CTO and Chief Scientist | 2019-01-15 | Option exercise · Stock Option (Right to Buy) | −35,000 | 13,391 | D | ||
| Open-market sales · 35,000 sh · avg $5.41 · $189,276 | |||||||
Loading xslF345X03/doc4.xml…